|
|
|
|
Science Sparks @ ACTREC
|
 14 August 2023 |
Vol. No. 12; Issue No. 591 |
|
|
Publications
|
|
1. Oak S, Karajgikar O, Teni T (2023). Curcumin mediates selective aggregation of mutant p53 in cancer cells a promising therapeutic strategy. Biochemical and Biophysical Research Communications.
2. Mundhe D, Mishra R, Basu S, Dalal S, Kumar S, Teni T (2023). ΔNp63 overexpression promotes oral cancer cell migration through hyperactivated Activin A signaling. Experimental Cell Research.
3. Chavan A, Shriyan B, Chavan P, Shirsat A, Gavhane U, Pillai B, Bhat V, Dhamne C, Gota V (2023). Covid antibody titers in cancer patients following vaccination with ChAdOx1 nCOV-19 vaccine. South Asian Journal of Cancer.
4. Gulia S, Kannan S, Ghosh J, Rath S, Maheshwari A, Gupta S (2023). Secondary cytoreduction in platinum sensitive relapsed ovarian cancer: An individual patient level meta-analysis. International Journal of Gynecological Cancer.
5. Sharma D, Pawar SN, Sulkshane P, Waghole R, Yasser M, Pawar SS, Kannan S, Chaudhary N, Kalwar A, Patil R, Nair S, Dalal SN, Teni T (2023). Elevated translationally controlled tumour protein promotes oral cancer progression and poor outcome. Journal of Oral Pathology and Medicine.
|
|
|
|
|
|
|
Video of the Week
|
|
| CAR T-cell therapy: Reprogramming the immune system to treat cancer |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1962, Stanley Cohen discovered the epidermal growth factor.
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
